Introduction: Hexahydrocannabinol or HHC has recently appeared on the Internet and in cannabidiol (CBD) stores in various forms. Although the abuse and dependence potential of HHC consumption has not yet been established, HHC has been reported by consumers to have effects similar to delta-9-tetrahydrocannabinol (THC) and has been classified as narcotics in France since June 12, 2023. Methods: We conducted a retrospective study of all cases of oral fluid samples collected from drivers by traffic police officers and sent to our laboratory to confirm the presence of illicit substances between June 12, 2023 and December 31, 2023. The presence of 33 psychoactive substances, including HHC, THC, and CBD, in the oral fluid samples was assessed by an ultra-high performance liquid chromatography system coupled to a triple quadrupole mass spectrometer. Results: Of the 867 oral fluid samples analyzed, 16 were positive for HHC and involved only male drivers aged between 19 and 58. The mean and median HHC concentrations found in oral fluid were 35 ± 69 ng/mL and 10 ng/mL, respectively. In these preliminary data, HHC was always associated with THC, but the THC/HHC and CBD/HHC ratios were very broad. Although the kinetics of HHC and THC in saliva are different, the 11 cases with the highest THC/HHC ratios (>300) support that impaired alertness in drivers may be mainly due to THC. In these 11 cases, a linear correlation was found between THC and HHC concentrations in oral fluid. Conclusion: Further large-scale studies are required to extend these preliminary data, but the emerging detection of HHC in oral fluid of drivers may illustrate its spreading use in the general population.

1.
United Nations Office on Drugs and Crime (UNODC)
.
World drug report 2023, executive summary
.
United Nations publication
;
2023
. Available from: https://www.unodc.org/res/WDR-2023/WDR23_Exsum_fin_SP.pdf
2.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
.
New cannabinoid HHC in the spotlight as market evolves, News 2023
;
2023
. Available from: https://www.emcdda.europa.eu/news/2023/new-cannabinoid-hhc-spotlight-market-evolves_en
3.
Ujváry
I
.
Hexahydrocannabinol and closely related semi-synthetic cannabinoids: a comprehensive review
.
Drug Test Anal
.
2024
;
16
(
2
):
127
61
.
4.
Russo
F
,
Vandelli
MA
,
Biagini
G
,
Schmid
M
,
Luongo
L
,
Perrone
M
, et al
.
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)
.
Sci Rep
.
2023
;
13
(
1
):
11061
.
5.
Höfert
L
,
Becker
S
,
Dreßler
J
,
Baumann
S
.
Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC-MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva
.
Drug Test Anal
.
2023
:
1
9
.
6.
Mercier
B
,
Scala-Bertola
J
,
Pape
E
,
Kolodziej
A
,
Gibaja
V
,
Bisch
M
, et al
.
Online SPE UPLC-MS/MS method for the simultaneous determination of 33 psychoactive drugs from swab-collected human oral fluid samples
.
Anal Bioanal Chem
.
2022
;
414
(
14
):
4203
15
.
7.
Di Trana
A
,
Di Giorgi
A
,
Sprega
G
,
Carlier
J
,
Kobidze
G
,
Montanari
E
, et al
.
Disposition of hexahydrocannabinol epimers and their metabolites in biological matrices following a single administration of smoked hexahydrocannabinol: a preliminary study
.
Pharmaceuticals
.
2024
;
17
(
2
):
249
.
8.
Kauert
GF
,
Ramaekers
JG
,
Schneider
E
,
Moeller
MR
,
Toennes
SW
.
Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid
.
J Anal Toxicol
.
2007
;
31
(
5
):
288
93
.
9.
Derne
AS
,
Pape
E
,
Jouzeau
JY
,
Kolodziej
A
,
Gambier
N
,
Scala-Bertola
J
.
Immunological detection of hexahydrocannabinol (HHC) in oral fluid
.
Drug Test Anal
.
2024
;
16
(
6
):
638
40
.
10.
Jones
AB
,
ElSohly
HN
,
ElSohly
MA
.
Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. V. Cross-reactivity of selected compounds in a radioimmunoassay
.
J Anal Toxicol
.
1984
;
8
(
6
):
252
4
.
You do not currently have access to this content.